Prevalence of Tuberculosis in Hadramout Al-Sahel, Yemen: A 1-Year Cross-Sectional Study
Clicks: 41
ID: 311187
2023
Article Quality & Performance Metrics
Overall Quality
Not rated
Combines reader engagement with the AI quality analysis. This
article has not been analysed, so there is no overall score —
reader engagement is measured and shown alongside.
Reader Engagement
Steady Performance
12.0
/100
41 views
1 readers
AI Quality Assessment
Not analyzed
Readership in this journal
SteadyRanked #4 of 254 articles by views in Yemen Journal of Medicine
Most read
Least read
Bar heights use a square-root scale. Only the 120 most-read articles are drawn; the journal has 254 in total.
Mint this article as an NFT
Not yet mintedCreate a permanent, verifiable on-chain record of this article on the Scimatic Network. The NFT is held in your Journament account, and you can withdraw it to your own wallet at any time.
5
SUSD
one-off · no wallet required
Abstract
Background: There is a lack of adequate data about the prevalence and types of tuberculosis (TB) disease in Hadramout Al-Sahel, Yemen. Hence, this study aimed to investigate the prevalence, types, and outcomes of TB disease in Hadramout Al-Sahel, Yemen.
Methods: This cross-sectional study was conducted at the National Tuberculosis Program (NTP) center in the city of Al Mukalla, Hadramout, Yemen. The study enrolled TB patients from different districts of Hadramout Al-Sahel who had registered at the NTP center between January 1 and December 31, 2021.
Results: A total of 127 new active TB cases were recruited, including 102 (80.3%) with pulmonary tuberculosis (PTB) and 25 (19.7%) with extrapulmonary tuberculosis (EPTB). The overall prevalence of TB disease in 2021 was 12.7 new TB cases per 100,000 population, while the median age of the study population was 38 years. The majority of cases (23.6%) belonged to the age group of 35-44 years. There were 85 (66.9%) males, and most patients (74; 58.3%) were identified in Al Mukalla City. EPTB was detected in 25 (19.7%) patients, with pleural effusion being the most frequent manifestation, found in 12 (48.0%) patients. All patients received 4-agent anti-TB therapies; 99 (77.9%) patients received anti-TB therapy for 6 months; 9 (7.1%) patients received anti-TB therapy for 9-12 months; 8 (6.3%) patients died during treatment and 11 (8.7%) patients were lost during follow-up. The majority of patients (108; 85%) were cured upon completion of treatment.
Conclusion: The prevalence of TB in Hadramout Al -Sahel was 12.7 cases per 100,000 population. Males were affected more than females; the pleura was the most commonly affected extrapulmonary site; and 85% of cases were cured. The results indicated the need to support the Al Mukalla NTP center, by providing more resources for improved TB reporting and for conduct of surveillance to detect new TB cases among high-risk groups. Health authorities are also urged to provide state hospitals with the equipment needed for TB diagnosis.
| Reference Key |
2026prevalence
Use this key to autocite in the manuscript while using
SciMatic Manuscript Manager or Thesis Manager
|
|---|---|
| Authors | Jamal M Basamed, Khaled Abdullah Alamoudi, Fahmi Yousef Khan |
| Journal | Yemen Journal of Medicine |
| Year | 2023 |
| DOI |
10.32677/yjm.v2i1.3906
|
| URL | |
| Keywords | Keywords not found |
Citations
No citations found. To add a citation, contact the admin at info@scimatic.org
Comments
No comments yet. Be the first to comment on this article.